A neuroscience perspective on anxiety proneness - Sex differences, monoaminergic pathways and treatment response

ppsala university0 个研究点开始时间: 2011年1月5日最近更新: 2012年8月28日

适应症

试验速览

暂无简介。

•1. Social anxiety disorder (social phobia), according to DSM-IV, must be the main diagnosis as assessed with the structured clinical interview for DSM disorders
•2. Otherwise somatically healthy
•3. Age 18 or older but not postmenopausal
•4. Willingness to participate in a symptom provocation brain imaging trial
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1. Treatment of social anxiety within the three months preceding the study
•2. Current serious or dominant psychiatric disorder other than social anxiety disorder (e.g., psychosis, major depressive disorder, bipolar disorder)
•3. Suicidal ideation
•4. Chronic use of prescribed medication that could influence the results
•5. Abuse of alcohol or narcotics
•6. Pregnancy or planned pregnancy during the study period
•7. Menopause
•8. Previous PET examination
•9. Contrainidications for MRI investigations (e.g. implants or other metal objects in the body, brain and heart operations)

发起方

ppsala university